Business Context and Reporting Period
This Form 8-K is filed by PerkinElmer, Inc. (Note: The request metadata lists "REVVITY, INC.", but the filing text identifies the registrant as PerkinElmer, Inc.) on November 4, 2010. The report discloses the announcement of financial results for the quarter ended October 3, 2010 (Third Quarter of 2010).
Key Financial Metrics
The filing text serves as a cover document referencing a press release (Exhibit 99.1) for detailed data. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for specific financial figures.
Material Changes
The filing does not contain specific numerical comparisons to prior periods. It solely confirms the announcement of the third-quarter results.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It explicitly states that the information in this Form 8-K and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor is it incorporated by reference into other filings except as expressly set forth.
Investor Verification Checklist
- Verify the specific revenue and earnings per share figures in the attached Exhibit 99.1 Press Release, as they are absent from the 8-K text.
- Confirm the company name discrepancy: The filing is for PerkinElmer, Inc., not REVVITY, INC. (PerkinElmer later spun off its clinical diagnostics business to form REVVITY).
- Note the legal disclaimer that the financial results in this report are "furnished" rather than "filed," limiting liability under Section 18 of the Exchange Act.
- Review the full press release for any guidance or outlook statements not summarized in this 8-K.